Format

Send to

Choose Destination
Neurosurgery. 1988 Jan;22(1 Pt 1):92-6.

Praziquantel (pyrazinoisoquinolone) in active cerebral cysticercosis.

Author information

1
Department of Neurosurgery, Wentworth Hospital, Durban, South Africa.

Abstract

A prospective open therapeutic study on volunteers with active neurocysticercosis using pyrazinoisoquinolone (Praziquantel) has shown that it is a safe and effective drug. Objective assessment of the effect of treatment was by high resolution sequential computed tomographic scanning. Sixty-six patients received the drug. Forty-one records were available for complete analysis at the end of 1 year of follow-up. The concomitant use of steroids reduced side effects significantly. A 98% improvement was achieved.

[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Silverchair Information Systems
Loading ...
Support Center